LATE-BREAKING ABSTRACT: An electronic nose distinguishes the exhaled breath of patients with pleural malignant mesothelioma from subjects with professional asbestos exposure

S. D. Dragonieri, P. C. Carratu, A. P. Pinca, N. S. Schiavulli, D. C. Cavone, M. T. Tutino, G. D. Degennaro, A. S. Spanevello, O. R. Resta, P. S. Sterk, M. M. Musti (Cassano delle Murge, Bari, Tradate, Italy; Amsterdam, Netherlands)

Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. D. Dragonieri, P. C. Carratu, A. P. Pinca, N. S. Schiavulli, D. C. Cavone, M. T. Tutino, G. D. Degennaro, A. S. Spanevello, O. R. Resta, P. S. Sterk, M. M. Musti (Cassano delle Murge, Bari, Tradate, Italy; Amsterdam, Netherlands). LATE-BREAKING ABSTRACT: An electronic nose distinguishes the exhaled breath of patients with pleural malignant mesothelioma from subjects with professional asbestos exposure. Eur Respir J 2009; 34: Suppl. 53, 3224

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Chemical characterization of exhaled breath to discriminate patients with malignant pleural mesothelioma from subjects with similar professional asbestos exposure
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010


Exhaled breath analysis allows exclusive screening for malignant pleural mesothelioma.
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Exhaled breath to screen for malignant pleural mesothelioma: a validation study
Source: Eur Respir J, 50 (6) 1700919; 10.1183/13993003.00919-2017
Year: 2017



A breath test for malignant mesothelioma using an electronic nose
Source: Eur Respir J 2012; 40: 448-454
Year: 2012



Pleural neoplasms – linkage with professional asbestos exposure
Source: Eur Respir J 2006; 28: Suppl. 50, 702s
Year: 2006

An electronic nose distinguishes the exhaled breath condensates of AATD patients and healthy controls
Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs
Year: 2008



Lung function in patients with benign asbestos related pleural disease
Source: Eur Respir J 2003; 22: Suppl. 45, 185s
Year: 2003

Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
Source: Eur Respir Rev, 27 (147) 170098; 10.1183/16000617.0098-2017
Year: 2018



Proportion of patients with malignant pleural mesothelioma whose asbestos body numbers in the lung are equal to general population
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


BAL and exhaled breath condensate in children: Is there any relationship between these fluids?
Source: Eur Respir J 2003; 22: Suppl. 45, 399s
Year: 2003

An electronic nose distinguishes the exhaled breath condensates of patient groups with COPD, alpha-1-antitrypsin deficiency and healthy controls
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006

The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Electronic nose versus exhaled no and bronchial challenge testing in asthma
Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function?
Year: 2009

Breath analysis allows to predict treatment response in malignant pleural mesothelioma patients.
Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease
Year: 2021



Different cytological alterations of bronchial mucosa in 178 smoking and non-smoking patients, suffering from COPD: the importance of endobronchial brushing
Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung
Year: 2009


The relationships between markers of inflammation in exhaled breath condensate and bronchoalveolar lavage in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 307s
Year: 2004

The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers
Source: International Congress 2016 – Molecular pathways of smoking-induced diseases
Year: 2016


Early detection of patients with asthma or chronic bronchitis by investigation on exhaled air condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 275s
Year: 2002

Association of exhaled breath condensate pH with markers of neutrophilic inflammation in bronchoalveolar lavage in young children with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more
Year: 2010